Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRECISION-E2: Teverelix in Women With Endometriosis in UAE
NCT07914062Phase 2Not yet recruiting
- Sponsor
- Antev
- Start
- Feb 2027
- Primary completion
- Dec 2029
01
Overview
A Phase 2 trial of teverelix in endometriosis, sponsored by Antev. Planned start Feb 2027; status: not yet recruiting.
02
Drugs
teverelix
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT07914062.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914062.